Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study - Drug Trials For Money - Paid Clinical Trials

Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study

Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
Conditions:   Acute Leukemia;   Deep Vein Thrombosis;   Hematopoietic and Lymphoid Cell Neoplasm;   Hodgkin Lymphoma;   Myeloproliferative Neoplasm;   Non-Hodgkin Lymphoma;   Plasma Cell Myeloma;   Thrombocytopenia
Interventions:   Procedure: Biospecimen Collection;   Other: Electronic Health Record Review
Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 23, 2021 / by / in
Comments